Skip to main content
Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · IEX Real-Time Price · USD
5.61
+0.02 (0.36%)
At close: May 2, 2024, 4:00 PM
5.60
-0.01 (-0.18%)
After-hours: May 2, 2024, 5:28 PM EDT

Sight Sciences Revenue

In the year 2023, Sight Sciences had annual revenue of $81.06M with 13.63% growth. Revenue in the quarter ending December 31, 2023 was $18.75M, a -8.72% decrease year-over-year.

Revenue (ttm)
$81.06M
Revenue Growth
+13.63%
P/S Ratio
3.44
Revenue / Employee
$378,766
Employees
214
Market Cap
279.07M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202381.06M9.73M13.63%
Dec 31, 202271.33M22.38M45.70%
Dec 31, 202148.96M21.32M77.12%
Dec 31, 202027.64M4.29M18.38%
Dec 31, 201923.35M15.82M210.07%
Dec 31, 20187.53M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 192.64M
Xeris Biopharma Holdings 163.91M
Agenus 156.31M
EDAP TMS 67.14M
Poseida Therapeutics 64.70M
Adaptimmune Therapeutics 60.28M
Senseonics Holdings 22.39M
Opthea 385.28K
Revenue Rankings

SGHT News

More News